TABLE 1.
Clinical and pathological characteristics in the groups analyzed
| Parameter |
VO n = 222 |
Non‐VO n = 135 |
P |
|---|---|---|---|
| Men | 120 (54.1) | 79 (58.5) | .41 |
| Age, y | 68.9 ± 11.3 | 63.3 ± 12.7 | <.001 |
| BMI, kg/m2 | 26.5 (24.2‐29.4) | 23.6 (21.6‐24.8) | <.001 |
| ERAS | 150 (67.6) | 99 (73.3) | .25 |
| Charlson's comorbidity index | 4 (3‐5) | 3 (2‐5) | .01 |
| Surgical indication | .93 | ||
| Colon cancer | 116 (52.3) | 72 (53.3) | |
| Rectal cancer | 54 (24.3) | 29 (21.5) | |
| Adenoma | 18 (8.1) | 11 (8.1) | |
| Diverticular disease | 34 (15.3) | 23 (17) | |
| Neoadjuvant therapy a | 25 (14.7) | 13 (12.9) | .67 |
| TNM stage a | .17 | ||
| TNM stage I/II | 111 (65.3) | 57 (56.4) | |
| TNM stage III/IV | 59 (34.7) | 44 (43.6) | |
| Surgical procedure | .84 | ||
| Right hemicolectomy | 73 (32.9) | 43 (31.9) | |
| Left hemicolectomy | 79 (35.6) | 51 (37.8) | |
| Rectal resection | 70 (31.6) | 41 (30.4) | |
| Associated resections | 47 (21.2) | 23 (17) | .34 |
| Surgical time, min | 237 (190‐297) | 220 (191‐270) | .18 |
| Blood loss, mL | 50 (30‐100) | 40 (30‐90) | .16 |
| Conversion | 18 (8.1) | 6 (4.4) | .18 |
| Overall complications | 94 (42.3) | 57 (42.2) | .98 |
| Minor grade | 77 (34.7) | 44 (32.6) | .78 |
| Major grade | 17 (7.7) | 13 (9.6) | .52 |
| Infectious complications | 34 (15.3) | 23 (17) | .67 |
| Pneumonia | 8 (3.6) | 7 (5.2) | .47 |
| Anastomotic leak | 12 (5.4) | 8 (5.9) | .84 |
| Surgical site infections | 11 (5) | 7 (5.2) | .92 |
| Time to infectious complication, d | 4 (2‐5.25) | 4 (3‐7) | .44 |
| Mortality | 1 (0.5) | 1 (0.7) | .72 |
| Readmission | 7 (3.2) | 5 (3.7) | .78 |
| Redo surgery | 10 (4.5) | 9 (6.7) | .38 |
| Length of stay, d | 6 (5‐8) | 6 (4‐8) | .30 |
Abbreviations: BMI, body mass index; ERAS, enhanced recovery after surgery; VO, visceral obesity.
a
Percentage on 271 colon and rectal cancers.